期刊文献+

LC-MS/MS法测定人血浆中非布司他及其活性代谢物67M-4的质量浓度

Determination of febuxostat and its active metabolite 67M-4 in human plasma by liquid chromatographytandem mass spectrometry
原文传递
导出
摘要 目的建立测定人血浆中非布司他及其活性代谢物67M-4质量浓度的LC-MS/MS方法。方法采用乙腈沉淀蛋白法处理血浆样品,采用不同的LC-MS/MS条件分别测定血浆中极性差异较大的非布司他和67M-4的质量浓度。非布司他的测定采用Platisil ODS(150 mm×4.6 mm,5μm)色谱柱和体积分数0.1%甲酸溶液-乙腈(体积比30∶70)为流动相;67M-4的测定采用Zorbax SB-C18(50 mm×4.6 mm,5μm)色谱柱和体积分数0.2%甲酸溶液-乙腈为流动相,梯度洗脱。质谱检测采用多反应离子选择监测(MRM)方式。结果血浆中非布司他和67M-4的质量浓度分别在0.010 00~15.06 mg·L-1和0.505 0~202.0μg·L-1内线性关系良好,提取回收率分别为88.0%~93.5%和88.7%~96.2%,方法的专属性,日内、日间精密度及基质效应均符合测定要求。结论该方法灵敏、可靠,适用于非布司他在人体内的药代动力学研究。 Objective To develop a rapid and sensitive LC-MS / MS method for the determination of febuxostat and its active carboxylic acid metabolite 67M-4 in human plasma. Methods Plasma samples were pretreated using protein precipitation with acetonitrile. Due to the great polarity differences between the two analytes,different LC-M S / M S conditions were employed to determine febuxostat and 67M-4 in human plasma separately. Febuxostat was analysed on a Platisil ODS( 150 mm × 4. 6 mm,5 μm) column with a mobile phase consisting of acetonitrile and 0. 2% formic acid aqueous solution( V ∶ V = 70∶ 30). The analysis of 67M-4was conducted on a Zorbax SB-C18( 50 mm ×4. 6 mm,5 μm) column using gradient elution with acetonitrile and 0. 1% formic acid aqueous solution as the mobile phase. M ass spectrometry detection was performed in multiple selected reaction monitoring( M RM) mode. Results The assay was linear over the concentration ranges of 0. 010 00- 15. 06 mg·L- 1for febuxostat and 0. 505 0- 202. 0 μg·L- 1for 67M-4,respectively. The extraction recoveries at low,middle,high level were 88. 0%- 93. 5% and 88. 7%- 96. 2%,respectively. The specificity,inter-and intra-run precisions and matrix effects met the requirements. Conclusions The method is accurate,sensitive,simple,and can be applied to pharmacokinetic study of febuxostat in human.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2015年第9期715-721,共7页 Journal of Shenyang Pharmaceutical University
关键词 高效液相色谱-质谱联用法 非布司他 67M-4 药代动力学 LC-MS/MS febuxostat 67M-4 pharmacokinetics
  • 相关文献

参考文献7

  • 1GRABOWSKI A B,KHOSRAVAN R,VERNILLET L,et al.Metabolism and excretion of[14C]febuxostat,a novel nonpurine selective inhibitor of Xanthine Oxidase,in healthy malesubjects[J].J Clin Pharmacol,2011,51:189-201.
  • 2MAYER M D,KHOSRAVAN R,VERNILLET L,et al.Pharmacokinetics and pharmacodynamics of febuxostat,a new non-purine selective inhibitor of Xanthine Oxidase in subjects with renal impairment[J].Am J Ther,2005,12:22-34.
  • 3KHOSRAVAN R,GRABOWSKI B,WU Jing-tao,et al.Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects[J].Br J Clin Pharmacol,2007,65:355-363.
  • 4张文丽,程航,阳国平.高效液相-荧光法测定人血浆中非布司他的浓度及其人体药动学研究[J].中国临床药理学与治疗学,2011,16(10):1148-1152. 被引量:7
  • 5LIU X X,LIU R J,DING L,et al.Pharmacokinetics of febuxostat in healthy Chinese[J].Arzneimittelforschung,2012,62:463-469.
  • 6张梅,邸晓辉,徐娟,杨永革,姜楠,宋丽雪,许雪廷.非布司他在中国健康人体内药动学和药效学[J].中国医院药学杂志,2013,33(12):942-945. 被引量:10
  • 7施政,刘健,申屠建中,吴国兰.非布司他片在中国健康人体的生物等效性[J].中国临床药理学杂志,2013,29(4):276-279. 被引量:13

二级参考文献14

  • 1国家食品药品监督管理局.化学药物临床药代动力学研究技术指导原则[S].2005:15-25.
  • 2Hair PI, McCormack PL, Keating GM. Febuxostat[J]. Drugs, 2008 ; 68 : 1865 - 1874.
  • 3Mayer MD, Khosravan R, Vemillet L, et al. Pharmacokinetics and pharmacodynamlcs of febuxostat, a new non -purine selective inhib- itor of xanthine oxidase, in subjects with renal impairment[ J]. Am J Ther, 2005 ; 12 : 22 - 34.
  • 4Khosravan R, Grabowski B, Wu .IT, et al. Pharmacokinetics, phar- macodynamics and safety of fubuxostat, a non - purine selective in- hibitor of xanthine oxidase, in a dose escalation study in healthy sub- jects[ J]. Clin Pharmacokinet, 2006 ; 45 : 821 - 841.
  • 5Khosravan R, Grabowski BA, Wu JT, et al. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects[J]. Br J Clin Pharmacol, 2007; 65 : 355 -363.
  • 6国家食品药品监督管理局.药品临床试验质量管理规范[s].2003.
  • 7Khosravan R, Grabowski B, Wu JT, et al. Effect of food and antacid on the pharmacokinetics and pharmacodynamics of fe- buxostat[J]. Brit J Clin Pharmaco,2007,65(3 ):355-363.
  • 8亚瑟.J.阿特金森,等著,魏伟,等译,临床药理学原理[M].2版,北京:科学出版社,2007.
  • 9陈艳,罗宇,吕伟.非布索坦的合成[J].中国医药工业杂志,2009,40(1):1-5. 被引量:22
  • 10韩莹,朱翊,傅得兴.非布司他治疗高尿酸血症伴痛风的药理与临床评价[J].中国新药与临床杂志,2010,29(8):635-638. 被引量:30

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部